NPPA hikes ceiling prices of 21 formulations by 50%
Saturday, December 14, 2019, 8:29 AM
In a major development that would help drug makers to tide over the high costs of active pharmaceutical ingredients (APIs) and intermediates, the NPPA has increased the ceiling price of 21 formulations by 50% on December 13. NPPA said it has been receiving applications for an upward revision of prices under para 19 of the DPCO, 2013, since the last two years.
NPPA approves hike in prices of coronary stents
Monday, April 1, 2019, 5:30 PM
Drug price regulator NPPA has approved hike in prices of cardiac stents by 4.2% in-line with the wholesale price index (WPI) of the previous calendar year, as per an official statement. As per the new prices notified by the National Pharmaceutical Pricing Authority (NPPA), a bare metal stent (BMS) would now cost Rs 8,261, while the drug eluting stent (DES) will cost Rs 30,080.